Dr. Danny R. Bartel, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical Branch at Galveston (1976)
- Years since graduation
- 50
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 987
Licensed in Texas since 1976, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1976Medical school: University of Texas Medical Branch at Galveston
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
TX license E6226 (first issued 1976; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- United Regional Health Care System Wichita Falls, TX
- Memorial Health Lawton, OK
- Graham Regional Medical Center Graham, TX
- Wilbarger General Hospital Vernon, TX
- Childress Regional Medical Center Childress, TX
Medical groups
- Danny R. Bartel, MD PA (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 987
- Services billed
- 136,510
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Injection, natalizumab, 1 mg | 39,600 | 20 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 28,808 | 757 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 12,158 | 13 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 6,079 | 796 |
| Established patient office or other outpatient visit, 30-39 minutes | 2,955 | 942 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 2,580 | 608 |
| Injection, dexamethasone sodium phosphate, 1 mg | 840 | 30 |
| Nerve conduction, 13 or more studies | 643 | 602 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 582 | 54 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 563 | 41 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levetiracetam Other prescribers in Wichita Falls, TX | 935 |
| Gabapentin Other prescribers in Wichita Falls, TX | 676 |
| Hydroxychloroquine Sulfate Other prescribers in Wichita Falls, TX | 506 |
| Meloxicam Other prescribers in Wichita Falls, TX | 488 |
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Wichita Falls, TX | 410 |
| Dexamethasone Other prescribers in Wichita Falls, TX | 394 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Wichita Falls, TX | 384 |
| Oxcarbazepine Other prescribers in Wichita Falls, TX | 380 |
| Pregabalin Other prescribers in Wichita Falls, TX | 299 |
| Tizanidine Hcl Other prescribers in Wichita Falls, TX | 295 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 42 companies reported 261 payments worth $5,119 in total to this clinician.
| UCB, Inc. | $488 |
|---|---|
| Biogen, Inc. | $398 |
| Neurocrine Biosciences, Inc. | $336 |
| Livanova USA, Inc. | $304 |
| Pfizer Inc. | $265 |
| Ani Pharmaceuticals, Inc. | $221 |
| Sk Life Science, Inc. | $217 |
| Teva Pharmaceuticals USA, Inc. | $199 |
| Food and Beverage | $4,963 |
|---|---|
| Education | $156 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Harmony Biosciences LLC Jul 3, 2025 | Education in-kind | $99.99 |
| Jazz Pharmaceuticals Inc. Apr 9, 2025 | Education EPIDIOLEX · NEUROLOGY · in-kind | $41.50 |
| Ani Pharmaceuticals, Inc. Jul 24, 2025 | Education PURIFIED CORTROPHIN GEL · Treatment of certain chronic autoimmune disorders including acute exacerbations · in-kind | $7.35 |
| Ani Pharmaceuticals, Inc. Aug 18, 2025 | Education PURIFIED CORTROPHIN GEL · Treatment of certain chronic autoimmune disorders including acute exacerbations · in-kind | $7.35 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.